Page last updated: 2024-11-06

prednisolone and Aberrant Tissue

prednisolone has been researched along with Aberrant Tissue in 2 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahrengart, L1
Lindgren, U1
Reinholt, FP1
Dufour, JP1
Lachapelle, JM1
Nagant de Deuxchaisnes, C1
Devogelaer, JP1
Noel, H1
Maldague, B1

Other Studies

2 other studies available for prednisolone and Aberrant Tissue

ArticleYear
Comparative study of the effects of radiation, indomethacin, prednisolone, and ethane-1-hydroxy-1,1-diphosphonate (EHDP) in the prevention of ectopic bone formation.
    Clinical orthopaedics and related research, 1988, Issue:229

    Topics: Animals; Bone and Bones; Choristoma; Drug Evaluation, Preclinical; Etidronic Acid; Immobilization; I

1988
Cutaneous mucinosis associated with multiple frozen joints and bony heterotopic deposits around the hips.
    Clinical rheumatology, 1986, Volume: 5, Issue:2

    Topics: Adult; Anti-Inflammatory Agents; Bone and Bones; Choristoma; Hip; Humans; Hydroxychloroquine; Joint

1986